AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2013
Oct 22, 2013
34975_dirs_2013-10-22_2a00248d-63b9-4ca2-8588-258ad3164f46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-10-18
Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-18 | Common Stock | M | 47247 | $3.18 | Acquired | 492764 | Direct |
| 2013-10-18 | Common Stock | F | 36265 | $5.50 | Disposed | 456499 | Direct |
| 2013-10-18 | Common Stock | M | 100000 | $1.99 | Disposed | 556499 | Direct |
| 2013-10-18 | Common Stock | F | 65960 | $5.50 | Disposed | 490539 | Direct |
| 2013-10-18 | Common Stock | M | 38025 | $4.28 | Disposed | 528564 | Direct |
| 2013-10-18 | Common Stock | F | 33377 | $5.50 | Disposed | 495187 | Direct |
| 2013-10-18 | Common Stock | M | 12500 | $2.98 | Disposed | 507687 | Direct |
| 2013-10-18 | Common Stock | F | 9343 | $5.50 | Disposed | 517030 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-10-18 | Stock option (right to buy) | $3.18 | M | 47247 | Disposed | 2019-05-21 | Common Stock, par value $0.01 per share (47247) | Direct |
| 2013-10-18 | Stock option (right to buy) | $1.99 | M | 100000 | Disposed | 2018-12-04 | Common Stock, par value $0.01 per share (100000) | Direct |
| 2013-10-18 | Stock option (right to buy) | $4.28 | M | 38025 | Disposed | 2016-08-09 | Common Stock, par value $0.01 per share (38025) | Direct |
| 2013-10-18 | Stock option (right to buy) | $2.98 | M | 12500 | Disposed | 2015-05-25 | Common Stock, par value $0.01 per share (12500) | Direct |
Footnotes
F1: Includes (a) a deferred stock award of 16,700 restricted stock units which will vest on Jan 1, 2014; (b) a deferred stock award of 9,374 restricted stock units which vest in equal installments on Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 30,954 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, and Jan 1, 2016; (d) and a deferred stock award of 19,337 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, Jan 1, 2016, and Jan 1, 2017; and (e) 369,152 shares of common stock held by Ms. Luscinski.
F2: Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price and related withholding taxes. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934.
F3: Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.